News

New ReproUnion Publication: Development and Validation of a Mass Spectrometry-based Assay for Quantification of Insulin-like Factor 3 in Human Serum.

Jun 4, 2018

Jakob Albrethsen, Ph.D. from Department of Growth and Reproduction from University Hospital of Copenhagen in Rigshospitalet has published an article in Clin. Chem. Lab. Med. (2018 May 30) in collaboration with Frederiksen H, Andersson AM, Anand-Ivell R, Nordkap L, Bang AK, Jørgensen N and Juul A.

In their publication, they present a robust and sensitive method suitable for quantitation of serum insulin-like factor 3 (INSL3) in large-scale clinical studies using LC-MS/MS instrumentation already available in modern hospital laboratories. The circulating level of the peptide hormone INSL3 is a marker of Leydig cell functionality and holds promise as a diagnostic marker in male subjects with andrological disorders and infertility. In addition, INSL3 is known to have anti-apoptotic effects on sperm and could be of interest as a therapeutic target in male fertility. In females, INSL3 is expressed by the Theca cells and is a possible marker for the polycystic ovarian syndrome and associated with female infertility. The presented method paves the way for future studies into the clinical role of serum INSL3.

Read the entire publication here

MORE NEWS


Welcome back Mette Bach Dyremose

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's communication efforts! With over 20 years of experience in strategic communication, business development, and life sciences,...

read more

RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Defective sperm doubles the risk of preeclampsia

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more